| Trinity Parmalee, SLP-CF | |
|
6400 Uptown Blvd Ne Ste 360, Albuquerque, NM 87110-4202 | |
| (505) 855-9893 | |
| Not Available |
| Full Name | Trinity Parmalee |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 6400 Uptown Blvd Ne Ste 360, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053021873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLPCF22002 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Trinity Parmalee, SLP-CF Po Box 25704, Albuquerque, NM 87125-0704 Ph: () - | Trinity Parmalee, SLP-CF 6400 Uptown Blvd Ne Ste 360, Albuquerque, NM 87110-4202 Ph: (505) 855-9893 |
News Archive
New research conducted by the scientific director for VGTI Florida and his colleagues at the University of Montreal, in collaboration with scientists from the NIH and the McGill University Hospital center, may soon lead to an expansion of the drug arsenal used to fight HIV. The research sheds new light on how HIV gradually weakens the body's immune system and highlights the need for new research into therapies that will target the chain of events that cause the progression of the disease.
Durata Therapeutics today announced the Company initiated a global, pivotal, Phase 3 study (DISCOVER-1) of its lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). The pivotal study is being conducted under a Special Protocol Assessment (SPA) agreed upon with the U.S. Food and Drug Administration (FDA).
A simple blood test can now predict whether newborn babies are at high risk of developing allergies as they grow older, thanks to research involving the University of Adelaide.
Among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, newly prescribed long-acting beta-agonists (LABAs) and inhaled corticosteroid combination therapy, compared with newly prescribed LABAs alone, was associated with a lower risk of death or COPD hospitalization, according to a study in the September 17 issue of JAMA.
› Verified 2 days ago
Elizabeth Y Kam, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7801 Candelaria Rd Ne, Sandia Hs, Albuquerque, NM 87110 Phone: 505-294-1511 | |
Ms. Brittney Amber Martinez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10800 Comanche Rd Ne Apt 329, Albuquerque, NM 87111 Phone: 505-927-8291 Fax: 505-266-6306 | |
Breanna White, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9500 Montgomery Blvd Ne Ste 215, Albuquerque, NM 87111 Phone: 505-247-4224 | |
Tyler Brewer, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6811 Taylor Ranch Rd Nw, Albuquerque, NM 87120 Phone: 505-898-1492 | |
Leslie Guzman, SLP-CF Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 6400 Uptown Blvd Ne, Suite 360w, Albuquerque, NM 87110 Phone: 505-855-9805 Fax: 505-848-9468 | |
Samantha Vance, SLP-CF Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6400 Uptown Blvd Ne Ste 360, Albuquerque, NM 87110 Phone: 505-299-9010 | |
Marsha Grover, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 412 Alameda Blvd Nw, Alameda Es, Albuquerque, NM 87114 Phone: 505-898-0070 |